实施标准化围手术期疼痛管理方案以减少耳鼻咽喉科手术阿片类药物处方
本研究在县医院耳鼻咽喉科实施标准化多模式围手术期疼痛管理方案,包括术前患者教育和按疼痛程度分层的术后多模式镇痛方案。回顾性分析210例患者(方案实施前105例、实施后105例),结果显示实施后平均处方吗啡毫克当量从132.5降至53.6(P<.05),各手术疼痛层级和手术类型的平均处方量均显著下降,患者术后1周平均疼痛评分为3.4,平均使用阿片类药物3.1天,仅使用了处方量的39%。
要点
- 实施标准化多模式围手术期疼痛管理方案后,平均处方吗啡毫克当量从132.5降至53.6(P<.05)。
- 各手术疼痛层级和手术类型的平均处方吗啡毫克当量均显著下降(P<.05)。
- 方案组患者术后1周平均疼痛评分为3.4,平均使用阿片类药物3.1天,仅使用处方量的39%。
核心结论
- 术前咨询和多模式围手术期疼痛方案标准化可有效降低耳鼻咽喉科手术的阿片类药物处方量,同时维持较低的术后疼痛水平。
研究设计与样本
- 回顾性队列研究,在县医院耳鼻咽喉科实施围手术期疼痛管理方案,比较方案实施前后患者队列的阿片类药物处方。
- 共分析210例患者,其中方案实施前105例,方案实施后105例。
主要发现
- 实施后平均处方吗啡毫克当量从132.5±117.8降至53.6±63.9(P<.05)。
- 轻度疼痛层级平均处方吗啡毫克当量从107.4降至40.5,中度从112.8降至48.1,高度从240.4降至105.0(均P<.05)。
- 内分泌手术平均处方吗啡毫克当量从105.6降至44.4,面部整形从225.0降至50.0,普通手术从160.9降至105.7,头颈肿瘤从138.6降至77.1,喉科从53.8降至12.5,耳科从77.5降至42.9,鼻科从142.2降至44.4,创伤从288.0降至24.5(均P<.05)。
- 方案组患者报告术后1周平均疼痛评分为3.4,平均使用阿片类药物3.1天,仅使用了处方阿片类药物的39%。
临床怎么用
- 作者认为,术前咨询和多模式围手术期疼痛方案标准化可有效降低耳鼻咽喉科手术的阿片类药物处方量,同时维持较低的术后疼痛水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy of implementing a standardized multimodal perioperative pain management protocol in reducing opioid prescriptions following otolaryngologic surgery. STUDY DESIGN: Retrospective cohort study. SETTING: County hospital otolaryngology practice. METHODS: A perioperative pain management protocol was implemented in adults undergoing otolaryngologic surgery. This protocol included preoperative patient education and a postoperative multimodal pain regimen stratified by pain level: mild, intermediate, and high. Opioid prescriptions were compared between patient cohorts before and after protocol implementation. Patients in the pain protocol were surveyed regarding pain levels and opioid use. RESULTS: We analyzed 210 patients (105 preprotocol and 105 postprotocol). Mean ± SD morphine milligram equivalents (MMEs) prescribed decreased from 132.5 ± 117.8 to 53.6 ± 63.9 (P < .05) following protocol implementation. Mean MMEs prescribed significantly decreased (P < .05) for each procedure pain tier: mild (107.4 to 40.5), intermediate (112.8 to 48.1), and high (240.4 to 105.0). Mean MMEs prescribed significantly decreased (P < .05) for each procedure type: endocrine (105.6 to 44.4), facial plastics (225.0 to 50.0), general (160.9 to 105.7), head and neck oncology (138.6 to 77.1), laryngology (53.8 to 12.5), otology (77.5 to 42.9), rhinology (142.2 to 44.4), and trauma (288.0 to 24.5). Protocol patients reported a mean 1-week postoperative pain score of 3.4, used opioids for a mean 3.1 days, and used only 39% of their prescribed opioids. CONCLUSION: Preoperative counseling and standardization of a multimodal perioperative pain regimen for otolaryngology procedures can effectively lower amount of opioid prescriptions while maintaining low levels of postoperative pain.
引用
- Chang MT, Lalakea ML, Shepard K, et al. Implementation of a Standardized Perioperative Pain Management Protocol to Reduce Opioid Prescriptions in Otolaryngologic Surgery. Otolaryngol Head Neck Surg. 2022. PMID: 35015583. doi:10.1177/01945998211071116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。